文献速递浆细胞疾病

AI驱动的全身MRI体成分指标揭示多发性骨髓瘤患者体成分与结局的独特关联

AI-derived whole-body MRI metrics in patients with multiple myeloma reveal unique insights into body composition and outcomes.
PubMed 文献 · Blood Adv · 2026-01-01

本研究开发基于深度学习的AI流程,从多发性骨髓瘤患者常规临床全身MRI中自动提取非病变组织的体成分定量指标。治疗期间腹部骨骼肌下降、皮下与内脏脂肪短暂增加(P<.001);基线腹部骨骼肌与皮下脂肪较高者无进展生存更好,内脏脂肪随时间增加则无进展生存更差。

要点

  • AI可从常规全身MRI自动提取骨髓瘤患者体成分指标。
  • 治疗中腹部骨骼肌下降伴皮下及内脏脂肪短暂增加。
  • 基线腹部骨骼肌和皮下脂肪较高与更好PFS相关。

核心结论

  • AI驱动的全身MRI体成分表型可作为可扩展的风险分层生物标志物(一致性指数0.725)并支持机制研究。

研究设计与样本

  • 开发基于深度学习的AI流程,从多发性骨髓瘤患者常规临床全身MRI中自动分割并定量非病变组织体成分。
  • 试验注册号NCT02403102。

主要发现

  • 治疗全程体成分发生显著纵向变化(P<.001),表现为腹部骨骼肌(ASM)下降,同时腹部皮下脂肪和内脏脂肪短暂增加。
  • 基线ASM较高与更好无进展生存相关(HR 0.60;95%CI 0.40-0.89)。
  • 基线腹部皮下脂肪较高与更好无进展生存相关(HR 0.67;95%CI 0.46-0.98)。
  • 内脏脂肪随时间增加与更差无进展生存相关(HR 2.89;95%CI 1.65-5.09)。

临床怎么用

  • 可利用诊断性全身MRI机会性进行体成分表型分析,辅助风险分层。
  • 关注治疗期间腹部骨骼肌下降及内脏脂肪增加,作为潜在风险信号。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with multiple myeloma are frequently exposed to prolonged, multiline and multidrug treatments, factors that may substantially influence overall health, physical reserve, and physiological resilience. Imaging of organs that are captured by whole-body scans can be opportunistically interrogated to derive direct, quantitative measures of body composition. Advances and standardization of whole-body magnetic resonance imaging (WBMRI) together with recent improvements in artificial intelligence (AI) methodologies for automated organ and tissue segmentation presents an opportunity to complement accurate disease assessments with body composition metrics. We report, to our knowledge, for the first time, development of an AI-based pipeline to enable automated quantitative image-derived phenotypes in nondiseased tissue from WBMRI in patients with multiple myeloma. We have demonstrated that a deep-learning pipeline can derive body composition metrics from routinely acquired clinical WBMRI. Throughout treatment, significant longitudinal changes were observed (P< .001), characterized by a decrease in abdominal skeletal muscle (ASM) alongside transient increases in abdominal subcutaneous and visceral adipose tissue. We have also shown that greater reserves of ASM (hazard ratio [HR], 0.60; 95% confidence interval [CI], 0.40-0.89) and abdominal subcutaneous adipose tissue (HR, 0.67; 95% CI, 0.46-0.98) at baseline are associated with better progression-free survival. Conversely increases in visceral adipose tissue over time was associated with inferior progression-free survival (HR, 2.89; 95% CI, 1.65-5.09). These findings support opportunistic body composition phenotyping from diagnostic WBMRI as a scalable biomarker for risk stratification (concordance index, 0.725) and mechanistic study. This trial was registered at www.clinicaltrials.gov as NCT02403102.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Basty N, Kaiser M, Pawlyn C, et al. AI-derived whole-body MRI metrics in patients with multiple myeloma reveal unique insights into body composition and outcomes. Blood Adv. 2026. PMID: 42418394. doi:10.1182/bloodadvances.2026020852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。